---
title: PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia
date: '2023-09-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37679323/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&fc=20220814223158&ff=20230908181155&v=2.17.9.post6+86293ac
source: (deep learning) AND ((leukemia) OR (lymphoma))
description: The deregulation of BCL2 family proteins plays a crucial role in leukemia
  development. Therefore, pharmacological inhibition of this family of proteins is
  becoming a prevalent treatment method. However, due to the emergence of primary
  and acquired resistance, efficacy is compromised in clinical or preclinical settings.
  We developed a drug sensitivity prediction model utilizing a deep tabular learning
  algorithm for the assessment of venetoclax sensitivity in T-cell acute lymphoblastic
  ...
disable_comments: true
---
The deregulation of BCL2 family proteins plays a crucial role in leukemia development. Therefore, pharmacological inhibition of this family of proteins is becoming a prevalent treatment method. However, due to the emergence of primary and acquired resistance, efficacy is compromised in clinical or preclinical settings. We developed a drug sensitivity prediction model utilizing a deep tabular learning algorithm for the assessment of venetoclax sensitivity in T-cell acute lymphoblastic ...